While TGFB and SOX2 were both previously identified as astrocytosis-promoting factors [21,22,23,24], TGFB was further shown to induce an astrocyte-specific developmental program that, in turn, prevents effective remyelination in MS plaques and periplaques [58]. This evidence concerns the gene SOX2 and myeloid sarcoma.